4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0000899243-22-026724
Chief Executive Officer sold 18,681 shares at $0.69 ($12,890)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Barrow Robert Chief Executive Officer | 2022-07-25 | Sale | −18,681 | $0.69 | $12,890 | 3,880,788 | D |
| Open-market sales · 18,681 sh · avg $0.69 · $12,890 | |||||||
Loading xslF345X03/doc4.xml…